McLellan At
Impact in
- Epidemiology top 10%
- Substance Abuse Treatment and Outcomes
-
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Schizophrenia research and treatment 4
-
- Substance Abuse Treatment and Outcomes 6
- HIV, Drug Use, Sexual Risk 2
- Co-authors
- O'Brien Cp (16 shared papers)Woody Ge (14 shared papers)Lester Luborsky (12 shared papers)I Maany (2 shared papers)Anita Hole (1 shared paper)Jennifer L. Cornish (1 shared paper)Robert A. Greenstein (1 shared paper)Joseph W. Ternes (1 shared paper)
- Journals
- American Journal of Psychiatry (1 paper)PubMed (31 papers)
- Partner nations
- United States
In The Last Decade
McLellan At
31 papers receiving 549 citations
Peers
Comparison fields: 5 of 68
- Epidemiology 355
- Cellular and Molecular Neuroscience 168
- Psychiatry and Mental health 126
- Clinical Psychology 154
- Experimental and Cognitive Psychology 72
Countries citing papers authored by McLellan At
This map shows the geographic impact of McLellan At's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by McLellan At with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites McLellan At more than expected).
Fields of papers citing papers by McLellan At
This network shows the impact of papers produced by McLellan At. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by McLellan At. The network helps show where McLellan At may publish in the future.
Co-authors
The 19 scholars most cited alongside McLellan At, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological and behavioral treatments of cocaine dependence: controlled studies. | 1988 | 89 |
| 2 | 1987 | 77 | |
| 3 | Psychotherapy for opiate addicts. | 1983 | 72 |
| 4 | The addiction severity index in three different populations. | 1984 | 46 |
| 5 | Psychotherapy and counseling for methadone-maintained opiate addicts: results of research studies. | 1990 | 41 |
| 6 | Patient treatment matching: a conceptual and methodological review with suggestions for future research. | 1991 | 35 |
| 7 | Psychiatric disorders in opioid-dependent patients. | 1984 | 34 |
| 8 | How effective is substance abuse treatment--compared to what? | 1992 | 34 |
| 9 | Unreinforced self-injections: effects on rituals and outcome in heroin addicts. | 1979 | 31 |
| 10 | Assessment and extinction of conditioned withdrawal-like responses in an integrated treatment for opiate dependence. | 1984 | 23 |
| 11 | Relative abuse liability of benzodiazepines in methadone maintained populations in three cities. | 1989 | 20 |
| 12 | Psychiatric symptoms, high risk behaviors and HIV positivity among methadone patients. | 1990 | 16 |
| 13 | Conditioning factors may help to understand and prevent relapse in patients who are recovering from drug dependence. | 1991 | 14 |
| 14 | Addressing psychiatric comorbidity. | 1991 | 13 |
| 15 | Categorizing substance abusers using the ASI: implications for evaluation and treatment. | 1990 | 9 |
| 16 | Certain types of substance abuse patients do better in certain kinds of treatments: evidence for patient-program matching. | 1981 | 7 |
| 17 | Increased effectiveness of drug abuse treatment from patient-program matching. | 1983 | 6 |
| 18 | How effective is LAAM treatment? Clinical comparison with methadone. | 1986 | 5 |
| 19 | Is drug abuse treatment effective? | 1982 | 4 |
| 20 | Abstinence treatments for opiate addicts: therapeutic community or naltrexone? | 1984 | 4 |
About McLellan At
McLellan At is a scholar working on Psychiatry and Mental health, Epidemiology, Clinical Psychology, Pharmacology and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 614 indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (6 papers), Schizophrenia research and treatment (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Opioid Use Disorder Treatment (3 papers), Treatment of Major Depression (3 papers), Health and Well-being Studies (2 papers), HIV, Drug Use, Sexual Risk (2 papers) and Mental Health Treatment and Access (2 papers). The work is most often cited by research in Epidemiology (355 citations), Cellular and Molecular Neuroscience (168 citations), Psychiatry and Mental health (126 citations), Clinical Psychology (154 citations) and Experimental and Cognitive Psychology (72 citations). McLellan At has collaborated with scholars based in United States. Frequent co-authors include O'Brien Cp, Woody Ge, Lester Luborsky, I Maany, Anita Hole, Jennifer L. Cornish, Robert A. Greenstein, Joseph W. Ternes, David S. Metzger and Harold C. Urschel. Their work appears in journals such as American Journal of Psychiatry and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.